Joseph Mancuso
About Joseph Mancuso
Joseph Mancuso is an Analytical CMC Strategy Senior Scientist at Bristol Myers Squibb with over 16 years of experience in the pharmaceutical and biotechnology industry.
Current Role at Bristol Myers Squibb
Joseph Mancuso currently holds the position of Analytical CMC Strategy - Senior Scientist at Bristol Myers Squibb, based in Devens, MA. He has been with the company in this role for over six years. His work primarily focuses on developing and implementing chemistry, manufacturing, and controls (CMC) strategies, utilizing his expertise in analytical chemistry.
Previous Experience at Galson Laboratories
From 2010 to 2016, Joseph Mancuso served as a Quality Assurance professional at Galson Laboratories in Devens, MA. During his six-year tenure, he was responsible for ensuring compliance with industry standards and regulations. His role involved maintaining high-quality standards and safeguarding the integrity of the laboratory’s processes and outputs.
Early Career Roles
Prior to his position at Galson Laboratories, Joseph Mancuso accumulated valuable experience as a Research Scientist at Bristol-Myers Squibb (2007-2008) and AMRI (2005-2007). These roles allowed him to develop a solid foundation in research methodologies and scientific analysis, contributing to his expertise in the pharmaceutical and biotechnology fields.
Educational Background from Cornell University
Joseph Mancuso earned his Bachelor of Science degree in Biological Sciences from Cornell University, studying from 2000 to 2004. His education at Cornell provided him with a robust understanding of biological principles, which later supported his career in analytical chemistry and CMC strategy development.
Expertise in Analytical Chemistry and CMC Strategy
With over 16 years of experience in the pharmaceutical and biotechnology industry, Joseph Mancuso possesses a strong background in analytical chemistry and CMC (Chemistry, Manufacturing, and Controls) strategy. His roles have spanned both research and quality assurance, equipping him with a well-rounded perspective on pharmaceutical development processes.